ARTICANZ - Beta (ver 0.9)
Annotated Registry of Trials in Cancer, Australia and New Zealand Ed.
- Results - location/VIC/3030-Heidelberg-Ballarat-Austin-Radiation-Oncology-Centre
Home
By cancer type
By drug class
By site
Data
FAQ
About
⚠
ARTICANZ provides informational content about cancer drug trials in Australia/NZ that is updated weekly but may not be completely accurate, and should not replace medical advice from qualified healthcare professionals. The platform is intended to be useful, providing information "as is" without warranties. Non-medical users must always consult healthcare providers for all clinical decisions.
Search results
1
trial(s) found.
NCT06094140
Curative
Phase 2
Active not recruiting
NEO-adjuvant Chemo-Immunotherapy in Pancreatic Cancer (
NEO-IMPACT
)
Durvalumab
Filgrastim
Fluorouracil
Gemcitabine
Irinotecan
Leucovorin
Oxaliplatin
Pegfilgrastim
anti-PD-L1 monoclonal antibody
antimetabolite
cancer therapy
cancer therapy,PD-1/PD-L1-targeting
cancer therapy,PD-L1-targeting
cytotoxic chemotherapy
fluoropyrimidine
immune checkpoint blockade
immune checkpoint blockade,PD-L1-targeting
immuno-oncology therapy,PD-L1-targeting
platinum-based antineoplastic agent
topoisomerase inhibitor
Pancreatic cancer
NSW
2065 - St Leonards - GenesisCare North Shore Private Hospital
2500 - Wollongong - Wollongong Hospital
VIC
3030 - Heidelberg - Ballarat Austin Radiation Oncology Centre
Additional search terms:
API and Webpage URLs:
Copy /Bookmark
Filters
Recruitment Status
Active not recruiting (1)
Recruitment Country and State
NSW (1)
VIC (1)
Phase
Phase 2 (1)
Trial Type
Curative (1)
Cancer Therapy Class
PD-1/PD-L1
100%
PD-L1
100%
Facility
2065 - St Leonards - GenesisCare North Shore Private Hospital (1)
2500 - Wollongong - Wollongong Hospital (1)
3030 - Heidelberg - Ballarat Austin Radiation Oncology Centre (1)
Cancer Type
Cancer
Gastrointestinal cancer
Pancreatic cancer
Pancreatobiliary cancer
Solid tumour
Upper gastrointestinal cancer
URLs for this search
API URL:
Copy
Bookmarkable URL:
Copy